Clinical Trials · NCT06003153
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 125
- Start date
- Mar 2024
- Locations
- 1 site, United States
- Primary endpoint
- Insulin response to oral semaglutide treatment